Opinion
Looking for the next CSL? Be vigilant, because bubbles abound
Fuelled by buoyant sentiment, it’s natural for astute investors to search for the next Australian hero, but beware adventures in biotech investing.
Jun Bei LiuBy any measure, 2019 has seen an incredible run in the equity market and there’s still one month to go. The ASX 200 has returned 19 per cent for the year to date, a stellar result that no one thought was likely this time last year.
The key change behind this rally was a sharp turn in stance across global central banks, particularly the Federal Reserve, which moved from tightening to loosening within the space of a few months.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles